What is Imatrex?
Imatrex Inc occupies a unique niche within the medical technology landscape, having transitioned from a primary developer of advanced medical imaging and image-guided radiotherapy equipment to a specialized service provider. The company is currently recognized for its dedicated support of Imatron EBCT Scanners across the United States. This pivot reflects a strategic focus on sustaining legacy medical hardware, providing essential technical oversight and maintenance for healthcare facilities that rely on high-precision diagnostic imaging tools. Their market position is defined by deep technical expertise in legacy radiotherapy and imaging systems, serving as a vital link for institutions managing complex medical equipment lifecycles.
How much funding has Imatrex raised?
Imatrex has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$648K
Debt (2020): $350K with participation from PPP
Debt (2021): $648K led by PPP
Key Investors in Imatrex
PPP
Public-Private Partnership
What's next for Imatrex?
Looking ahead, the strategic deployment of $998K suggests a focus on operational stability and the preservation of existing service contracts. As the medical imaging sector continues to evolve toward digital integration and AI-driven diagnostics, Imatrex's role in maintaining foundational hardware remains a critical component of the broader healthcare ecosystem. The company is well-positioned to continue its service-oriented model, potentially exploring further efficiencies in its maintenance protocols or evaluating the long-term viability of its legacy equipment portfolio. Future growth will likely depend on the company's ability to balance its service obligations with the shifting technological requirements of modern clinical environments, ensuring that its specialized expertise remains an asset to the medical imaging community.
See full Imatrex company page
